Literature DB >> 17853252

Deficit of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia.

Victor Vostrikov1, Diana Orlovskaya, Natalya Uranova.   

Abstract

OBJECTIVE: Our previous studies have shown a significant decrease of numerical density of oligodendrocytes in the prefrontal cortex in postmortem schizophrenic brains. Deficit of oligodendrocytes was associated with loss of oligodendroglial satellites of pyramidal neurons. In this study we tested the hypothesis that there might be a deficit and loss of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia.
METHOD: Autopsy samples from the prefrontal cortex (BA 10) were obtained from 12 normal controls and 12 chronic schizophrenic cases. Capillaries and oligodendrocytes were viewed in paraffin sections stained with a Luxol-fast blue and cresyl violet. Electron microscopy was applied to study the ultrastructure of oligodendrocytes. For morphometric analysis, an average of 100 rectilinear capillary segments from layer V was sampled for each individual. The number of oligodendrocytes visible along rectilinear segments was expressed as the number of oligodendrocytes per 0.01 mm of capillary length.
RESULTS: Subjects with schizophrenia had a significantly lower (-23%; P < 0.005) number of pericapillary oligodendrocytes compared to controls. Prominent ultrastructural dystrophic and degenerative alterations of pericapillary oligodendrocytes have been revealed in schizophrenic brains.
CONCLUSION: The present study provides evidence that there is a prominent reduction, damage and loss of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia. These changes may contribute to the pathophysiological basis for altered blood-brain barrier and lowered metabolic rates in subjects with schizophrenia.

Entities:  

Mesh:

Year:  2008        PMID: 17853252     DOI: 10.1080/15622970701210247

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  14 in total

1.  Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

Authors:  Kirsten E Schoonover; Stacy L Queern; Suzanne E Lapi; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2018-12-20       Impact factor: 4.132

2.  Abnormal Grey Matter Arteriolar Cerebral Blood Volume in Schizophrenia Measured With 3D Inflow-Based Vascular-Space-Occupancy MRI at 7T.

Authors:  Jun Hua; Allison S Brandt; SeungWook Lee; Nicholas I S Blair; Yuankui Wu; Su Lui; Jaymin Patel; Andreia V Faria; Issel Anne L Lim; Paul G Unschuld; James J Pekar; Peter C M van Zijl; Christopher A Ross; Russell L Margolis
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

Review 3.  Microvascular anomaly conditions in psychiatric disease. Schizophrenia - angiogenesis connection.

Authors:  Pavel Katsel; Panos Roussos; Mikhail Pletnikov; Vahram Haroutunian
Journal:  Neurosci Biobehav Rev       Date:  2017-04-08       Impact factor: 8.989

Review 4.  Myelin, copper, and the cuprizone model of schizophrenia.

Authors:  Nicole R Herring; Christine Konradi
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

5.  In vivo spatiotemporal patterns of oligodendrocyte and myelin damage at the neural electrode interface.

Authors:  Keying Chen; Steven M Wellman; Yalikun Yaxiaer; James R Eles; Takashi Dy Kozai
Journal:  Biomaterials       Date:  2020-11-23       Impact factor: 12.479

6.  Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis.

Authors:  Kirsten E Schoonover; Charlene B Farmer; Charity J Morgan; Vidushi Sinha; Laura Odom; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2021-01-09       Impact factor: 4.939

7.  Schizophrenia: a pathogenetic autoimmune disease caused by viruses and pathogens and dependent on genes.

Authors:  C J Carter
Journal:  J Pathog       Date:  2011-05-26

8.  Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study.

Authors:  Natalya A Uranova; Olga V Vikhreva; Valentina I Rachmanova; Diana D Orlovskaya
Journal:  Schizophr Res Treatment       Date:  2011-06-28

9.  Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders.

Authors:  Victor Vostrikov; Natalya Uranova
Journal:  Schizophr Res Treatment       Date:  2011-07-03

10.  Neuropathological changes in the substantia nigra in schizophrenia but not depression.

Authors:  M R Williams; K Galvin; B O'Sullivan; C D MacDonald; E W K Ching; F Turkheimer; O D Howes; R K B Pearce; S R Hirsch; M Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-12-29       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.